StreetAlpha
13F holdings · Q3 2026

ABG-WTT Global Life Science Capital Partners GP

Central, Hong Kong, K3 · files as ABG-WTT Global Life Science Capital Partners GP Ltd
Know the moment ABG-WTT Global Life Science Capital Partners GP filesYou follow ABG-WTT Global Life Science Capital Partners GP An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1832108

ABG-WTT Global Life Science Capital Partners GP reported 1 stock worth $1.9M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RPID (100.0%). Compared with Q2 2026, the fund sold out of CBLL.

Latest filing: what ABG-WTT Global Life Science Capital Partners GP did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
0 new0 added0 trimmed1 sold outBought about $0 · sold about $5.4M
New 0

None

Added 0

None

Trimmed 0

None

Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.9M−77.7% vs last quarter
Stocks held10 new · 1 sold out
Top 5 weight100.0%very concentrated
Turnover281%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
RPID
Rapid Micro Biosystems Inc
$1.9M100.0%1.8MNo change8 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CBLL
Ceribell Inc
$5.4M275K

Reported value

last 8 quarters
$43.7MQ4 '24
$38.3MQ1 '25
$26.8MQ2 '25
$18.7MQ3 '25
$15MQ4 '25
$12.3MQ1 '26
$8.6MQ2 '26
$1.9MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

ABG-WTT Global Life Science Capital Partners GP 13F FAQ

What does ABG-WTT Global Life Science Capital Partners GP own?

ABG-WTT Global Life Science Capital Partners GP reported 1 stock worth $1.9M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RPID (100.0%). The table above lists every position in the filing (the top 10 without an account).

What did ABG-WTT Global Life Science Capital Partners GP buy and sell in Q3 2026?

Compared with Q2 2026: 0 new positions, 0 added to, 0 trimmed and 1 sold out. It sold all of CBLL.

When will ABG-WTT Global Life Science Capital Partners GP file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is ABG-WTT Global Life Science Capital Partners GP's portfolio worth?

The Q3 2026 filing reports $1.9M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.